Fiera Capital Corp lessened its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 3.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,258,855 shares of the company's stock after selling 40,756 shares during the period. Fiera Capital Corp owned about 0.66% of ChampionX worth $37,954,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of CHX. Allspring Global Investments Holdings LLC purchased a new position in ChampionX in the first quarter worth $27,000. Blue Trust Inc. grew its stake in ChampionX by 442.4% during the 3rd quarter. Blue Trust Inc. now owns 1,329 shares of the company's stock worth $44,000 after buying an additional 1,084 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new position in ChampionX during the 2nd quarter worth $68,000. UMB Bank n.a. grew its stake in ChampionX by 63.7% during the 3rd quarter. UMB Bank n.a. now owns 2,266 shares of the company's stock worth $68,000 after buying an additional 882 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC purchased a new position in ChampionX during the 2nd quarter worth $194,000. Institutional investors own 98.99% of the company's stock.
Wall Street Analyst Weigh In
Separately, Piper Sandler dropped their target price on ChampionX from $40.00 to $33.00 and set a "neutral" rating on the stock in a research note on Monday, July 15th.
Read Our Latest Analysis on ChampionX
Insiders Place Their Bets
In other news, insider Deric D. Bryant sold 49,303 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $30.06, for a total value of $1,482,048.18. Following the completion of the sale, the insider now directly owns 337,409 shares in the company, valued at $10,142,514.54. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.38% of the stock is owned by company insiders.
ChampionX Stock Performance
ChampionX stock traded down $0.07 during trading hours on Friday, hitting $30.79. 1,258,469 shares of the stock traded hands, compared to its average volume of 1,934,215. The stock has a market capitalization of $5.87 billion, a price-to-earnings ratio of 19.12 and a beta of 2.38. ChampionX Co. has a 1 year low of $25.46 and a 1 year high of $39.95. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.94 and a quick ratio of 1.20. The firm's 50 day moving average price is $30.07 and its 200-day moving average price is $31.80.
ChampionX (NASDAQ:CHX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The company reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). ChampionX had a return on equity of 19.74% and a net margin of 8.59%. The firm had revenue of $906.53 million for the quarter, compared to analysts' expectations of $916.50 million. During the same quarter last year, the firm posted $0.41 earnings per share. ChampionX's quarterly revenue was down 3.5% on a year-over-year basis. As a group, equities analysts expect that ChampionX Co. will post 1.66 EPS for the current fiscal year.
ChampionX Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, October 4th were paid a dividend of $0.095 per share. The ex-dividend date was Friday, October 4th. This represents a $0.38 annualized dividend and a yield of 1.23%. ChampionX's dividend payout ratio (DPR) is currently 23.60%.
ChampionX Company Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Featured Articles
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.